NervGen Pharma Corp. (NGEN)
2.07
-0.01
(-0.48%)
USD |
NASDAQ |
May 29, 16:00
2.06
-0.01
(-0.48%)
After-Hours: 20:00
NervGen Pharma Shareholders Equity (Quarterly) : 3.971M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| Milestone Pharmaceuticals, Inc. | 36.05M |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | 8.238M |
| Pharmagreen Biotech, Inc. | -9.351M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.88M |
| Total Liabilities (Quarterly) | 10.91M |
| Current Ratio | 1.338 |
| Net Debt Paydown Yield | 0.00% |